Teradyne Inc reports results for the quarter ended June 30 - Earnings Summary
Teradyne Inc reports results for the quarter ended June 30 - Earnings Summary
Teradyne Inc TER.OQ reported quarterly adjusted earnings of $2.47 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 57 cents. The mean expectation of sixteen analysts for the quarter was for earnings of $2.09 per share. Wall Street expected results to range from $2.00 to $2.65 per share.
Revenue rose 103.9% to $1.33 billion from a year ago; analysts expected $1.22 billion.
Teradyne Inc's reported EPS for the quarter was $2.38.
The company reported quarterly net income of $374.5 million.
Teradyne Inc shares had fallen by 30.8% this quarter and gained 73.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 5.3% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the semiconductor equipment & testing peer group is also "buy"
Wall Street's median 12-month price target for Teradyne Inc is $446.00, about 24.9% above its last closing price of $334.77
This summary was machine generated from LSEG data July 28 at 10:55 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 2.09 | 2.47 | Beat |
Mar. 31 2026 | 2.10 | 2.56 | Beat |
Dec. 31 2025 | 1.36 | 1.80 | Beat |
Sep. 30 2025 | 0.79 | 0.85 | Beat |
Recent news on Teradyne
See all newsBrief: Teradyne Robotics And Sereact Announce Partnership To Scale Physical AI Solutions
Brief: Formfactor And Teradyne Announce Strategic Collaboration To Accelerate Next-Generation Semiconductor Testing
Brief: Multiply Labs Raises $75 Mln Series B Led By AstraZeneca, Teradyne
Brief: GSME And Teradyne Announce Strategic Partnership
Brief: GSME And Teradyne Announce Strategic Partnership